These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 799549)

  • 1. Pharmacologically active drug metabolites: therapeutic and toxic activities, plasma and urine data in man, accumulation in renal failure.
    Drayer DE
    Clin Pharmacokinet; 1976; 1(6):426-43. PubMed ID: 799549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active drug metabolites and renal failure.
    Drayer DE
    Am J Med; 1977 Apr; 62(4):486-9. PubMed ID: 851118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug metabolism and active drug metabolites in renal failure.
    Reidenberg MM; Drayer DE
    J Dial; 1977; 1(4):313-8. PubMed ID: 608854
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of active metabolites on monitoring plasma concentrations of therapeutic drugs.
    Atkinson AJ; Stec GP; Lertora JJ; Ruo TI; Thenot JP
    Ther Drug Monit; 1980; 2(1):19-27. PubMed ID: 6762700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of renal excretion of pethidine (meperidine) and its metabolites in old and young patients.
    Odar-Cederlöf I; Boréus LO; Bondesson U; Holmberg L; Heyner L
    Eur J Clin Pharmacol; 1985; 28(2):171-5. PubMed ID: 3987796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolites of cardiac antiarrhythmic drugs: their clinical role.
    Kates RE
    Ann N Y Acad Sci; 1984; 432():75-89. PubMed ID: 6441496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug metabolites in renal failure: pharmacokinetic and clinical implications.
    Verbeeck RK; Branch RA; Wilkinson GR
    Clin Pharmacokinet; 1981; 6(5):329-45. PubMed ID: 7037261
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetics in patients with cardiac failure.
    Benowitz NL; Meister W
    Clin Pharmacokinet; 1976; 1(6):389-405. PubMed ID: 799548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cumulation of N-acetylprocainamide, an active metabolite of procainamide, in patients with impaired renal function.
    Drayer DE; Lowenthal DT; Woosley RL; Nies AS; Schwartz A; Reidenberg MM
    Clin Pharmacol Ther; 1977 Jul; 22(1):63-9. PubMed ID: 872496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacokinetics of N-acetylprocainamide.
    Connolly SJ; Kates RE
    Clin Pharmacokinet; 1982; 7(3):206-20. PubMed ID: 6178545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some consequences of drug choice and dosage regimen for patients with impaired kidney function.
    Vree TB; Hekster CA; van Dalen R
    Drug Intell Clin Pharm; 1983 Apr; 17(4):267-73. PubMed ID: 6839956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of metabolites in antiarrhythmic therapy.
    Woosley RL; Roden DM
    Am J Cardiol; 1983 Sep; 52(6):3C-7C. PubMed ID: 6194679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poisoning due to class IA antiarrhythmic drugs. Quinidine, procainamide and disopyramide.
    Kim SY; Benowitz NL
    Drug Saf; 1990; 5(6):393-420. PubMed ID: 2285495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacokinetics of angiotensin converting enzyme (ACE) inhibitors in renal failure.
    Hoyer J; Schulte KL; Lenz T
    Clin Pharmacokinet; 1993 Mar; 24(3):230-54. PubMed ID: 8462229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologically active drug metabolites: impact on drug discovery and pharmacotherapy.
    Obach RS
    Pharmacol Rev; 2013 Apr; 65(2):578-640. PubMed ID: 23406671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacokinetics of procainamide.
    Karlsson E
    Clin Pharmacokinet; 1978; 3(2):97-107. PubMed ID: 346289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lethal accumulation of procainamide metabolite in severe renal insufficiency.
    Vlasses PH; Ferguson RK; Rocci ML; Raja RM; Porter RS; Greenspan AM
    Am J Nephrol; 1986; 6(2):112-6. PubMed ID: 2422935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics in patients with renal failure.
    Maher JF
    Clin Nephrol; 1984 Jan; 21(1):39-46. PubMed ID: 6368069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacokinetics of methyldopa.
    Myhre E; Rugstad HE; Hansen T
    Clin Pharmacokinet; 1982; 7(3):221-33. PubMed ID: 7047042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug dosing guidelines in patients with renal failure.
    Swan SK; Bennett WM
    West J Med; 1992 Jun; 156(6):633-8. PubMed ID: 1615656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.